Sun Pharma Signs License Agreement with SPARC to Commercialise Drug in US Market
Pharmaceutical giant Sun Pharma said on Wednesday it had signed a licensing deal with Sun Pharma Advanced Research Company to commercialise a drug for neonatal...
Tag : USFDA
IndusInd Bank, Havells India, Tracxn Technologies, BEL, Persistent Systems in Focus
IndusInd Bank reported a 57 per cent rise in net profit to Rs 1805 crore on a 15 per cent increase in revenue to Rs...
Back-to-Back USFDA Approvals Boost Zydus Lifesciences, Shares Hit 8-Month High
Zydus Lifesciences’ drug hit an eight-month high following a string of US regulatory approvals. The stock hit Rs 426 on the NSE on October 7...
Aurobindo Pharma Falls 6% in One Week After Receiving EIR from USFDA
Shares of Aurobindo Pharma fell 1% to Rs 497.85 in intra-day trade on Tuesday for the fifth consecutive day after the company’s half-subsidiary Aurolife received...
Alkem Laboratories Gets Form 483 Approval From USFDA
On Thursday, Alkem Laboratories announced that the USFDA had issued Form 483. They issued two observations after the approval inspection of its St Louis facility....
Sensex Declines 800 Points, Dragged by Financials and IT Shares After GDP Data
India’s stock market benchmark fell sharply on Thursday as Dalal Street resumed trading after a one-day holiday, weighed down by losses in financials, IT, oil...
Alembic Gets USFDA Approval for Cancer Treatment Drug
Alembic Pharmaceuticals said in a statement it had received approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Dasatinib tablets of 20...
Lupin Gets Generic Drug Approval from USFDA
Drugmaker Lupin said on Wednesday it had received preliminary approval from US health regulators to sell Ivacaftor tablets for cystic fibrosis in the US. In...
Zydus Receives USFDA Approval for Generic Antacid
On Monday, Zydus Lifesciences said that it had received final approval from US health regulators to market its antacid famotidine tablets in the US market....
Second Dose of Covid Booster for Most Vulnerable Could Bring Benefits, WHO Says
As omicron and its sub-variants continue to spread globally, there may be some benefit to delivering a second dose of a coronavirus booster vaccine to...